Cannabidiol placed under the tongue for knee osteoarthritis
Tests cannabidiol against placebo in people with knee osteoarthritis.
Key facts
- Who runs it
- University of Florida
- Where
- Gainesville, United StatesSee the site
- Trial code
- Registry title
- CBD for Knee Osteoarthritis
- Status
- Recruiting
- Phase
- Phase 1/2
- People taking part
- 30 people, planned
- Started
- 14 Jun 2024
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Cannabidiol (CBD) Extract
- Placebo
- Record updated
- 17 September 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with knee osteoarthritis who have moderate to severe knee pain during physical activity. It tests a CBD (cannabidiol) extract taken under the tongue against a placebo.
- Age
- 40 Years to 75 Years
- Sex
- All sexes
- Disease stage
- A doctor's diagnosis of knee osteoarthritis, with knee pain of 4/10 or more during physical activity, in one or both knees.
- Earlier treatment
- People who had major surgery within 3 months before recruitment cannot join. People who took another study drug within 3 months before screening cannot join.
Main reasons for not taking part
- Pregnant (checked by urine test) or breastfeeding
- Current cannabis use (THC and/or CBD), checked by urine drug test
- BMI of 45 or more
- Current use of drugs that strongly change how liver CYP enzymes work
- History of suicidal thoughts or self-harm, seizures or brain injury, liver or kidney disease, or heart and blood vessel disease
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- established clinical diagnosis of knee osteoarthritis (KOA)
- moderate to severe knee pain (≥4/10) with physical activity in one or both knees
Who cannot take part
- current cannabis (THC and/or CBD) use (urine drug screen)
- any prior or ongoing medical condition that, in the investigators' opinion, could adversely affect the safety of the subject
- any major surgery within 3 months prior to recruitment or planned orthopedic surgery for any time during this study which would interfere with the ability to report pain or quality of life outcome measures
- any exposure to another investigational drug within 3 months prior to screening
- current use of any enzyme-modifying drugs, including strong inhibitors or strong inducers of cytochrome P (CYP) enzymes
- history of:; suicidal ideation or self-harm behavior; seizure disorder or traumatic brain injury,; liver or kidney disease, and; cardiovascular diseases
- pregnant (urine pregnancy test) or lactating
- BMI ≥ 45
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 40 and 75 years old?
Where in United States
- Sports Medicine Research LaboratoryGainesville, United StatesContact: Paul A Borsa, PhDTaking people
About the trial
What the trial wants to find out
Osteoarthritis is a disease that affects millions of Americans and is the leading cause of persistent pain and physical disability in the older adult population. Many physically active Americans have reported pain-relieving effects of cannabidiol (CBD) that can reduce or eliminate use of nonsteroidal anti-inflammatory drugs (NSAIDs) for activity-related pain with minimal to no side effects. Long-term use of over-the-counter medications, including NSAIDs, can pose a significant health risk, and therefore clinical research on the safety and efficacy of CBD is needed.
The 2 groups in the trial
- Active DrugExisting treatment, for comparison
Hemp supplement is a full spectrum CBD-rich formulation (\~10%) containing very low levels of THC (\<0.3%), along with all naturally occurring minor cannabinoids, terpenes, and essential oils from the plant extract.
Treatment: Cannabidiol (CBD) Extract
- Vehicle ControlPlacebo, for comparison
A medium chain triglyceride-based mixing agent blended with coconut oil will be used as the placebo.
Treatment: Placebo
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Sub-Lingual Administration of Cannabidiol for Knee Osteoarthritis
- Plain-language title
- Cannabidiol placed under the tongue for knee osteoarthritisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT06414473, who can take part
- Record updated
- 17 September 2025